Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Clinical Phenotype of Adult Atopic Dermatitis.

CONCLUSIONS: Generalized prurigo nodularis is currently also considered as a rather common clinical pattern of adult AD. Dupilumab can be an efficacious treatment of this condition, especially in cases where history of atopy is recorded and conventional treatments are ineffective. PMID: 31517666 [PubMed - as supplied by publisher]
Source: Dermatitis - Category: Dermatology Authors: Tags: Dermatitis Source Type: research

Related Links:

CONCLUSIONS: In adolescents with moderate-to-severe AD, dupilumab's pharmacokinetic profile was similar to that in adults. These 52-week safety and efficacy data support long-term use of dupilumab in this patient population. What's already known about this topic? Adolescents with moderate-to-severe atopic dermatitis (AD) have high unmet medical need, with significant disease burden and limited treatment options. Dupilumab (monoclonal antibody against interleukin-4 receptor α) is approved for the treatment of adolescents with moderate-to-severe AD who are inadequately responsive to standard of care (U.S.A.) or candida...
Source: The British Journal of Dermatology - Category: Dermatology Authors: Tags: Br J Dermatol Source Type: research
Conclusion: The study results validate that the botanical combination is the key factor for the efficacy and improvement of the AD symptoms within this population of children. J Drugs Dermatol. 2019;18(10):1038-1045. PMID: 31584783 [PubMed - as supplied by publisher]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
Conditions:   Atopic Dermatitis;   Atopic Eczema Interventions:   Drug: Betnovate, betamethasone dipropionate ointment 0.1% and placebo;   Drug: Protopic, tacrolimus ointment 0.1% Sponsors:   Jacob Thyssen;   LEO Pharma Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
LOS ANGELES, Oct. 3, 2019 -- (Healthcare Sales &Marketing Network) -- Turn Therapeutics™, Inc., a Los Angeles-based pharmaceutical and medical device company, has announced the closing of its fully-subscribed series B financing. The capital raised will f... Biopharmaceuticals, Dermatology, Venture Capital Turn Therapeutics, AtopX, Eczema Emulsion, PermaFusion
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
CBS News Miami anchor Frances Wang, 27, was diagnosed this year with perioral dermatitis, a skin condition that occurs due to prolonged use of topical steroid creams for her eczema.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
ConclusionIn early infancy, distinct parental and pregnancy-related factors were predictive for dry skin, high TEWL and AD. Dry skin at 3 months of age was predictive for AD three months later.
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Condition:   Atopic Dermatitis Eczema Intervention:   Other: Ectoin Dermatitis Cream 7% (EHK02) Sponsor:   Bitop AG Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dermatitis | Dermatology | Eczema | Skin | Study